Together, our findings provide new evidence about the important role of SMOC1 in AD and provide new context for why SMOC1 is consistently reported as a leading fluid biomarker for early AD in proteomic studies [42, 48–50, 87, 109, 115, 117, 127]. This evidence concerns the gene SMOC1 and Alzheimer disease.